IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,226 | +44.4% | 11,448 | +30.7% | 0.00% | 0.0% |
| Q2 2023 | $359,559 | +5.5% | 8,761 | -8.1% | 0.00% | 0.0% |
| Q1 2023 | $340,966 | -16.5% | 9,535 | -11.9% | 0.00% | 0.0% |
| Q4 2022 | $408,331 | -19.9% | 10,829 | -6.1% | 0.00% | 0.0% |
| Q3 2022 | $510,000 | -21.1% | 11,535 | -33.8% | 0.00% | 0.0% |
| Q2 2022 | $646,000 | -11.3% | 17,424 | -10.9% | 0.00% | 0.0% |
| Q1 2022 | $728,000 | +24.9% | 19,566 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $583,000 | -5.8% | 19,147 | +3.8% | 0.00% | 0.0% |
| Q3 2021 | $619,000 | -25.7% | 18,441 | -11.8% | 0.00% | -50.0% |
| Q2 2021 | $833,000 | +15.7% | 20,903 | +30.9% | 0.00% | 0.0% |
| Q1 2021 | $720,000 | -4.9% | 15,966 | +19.3% | 0.00% | 0.0% |
| Q4 2020 | $757,000 | +27.2% | 13,378 | +6.3% | 0.00% | 0.0% |
| Q3 2020 | $595,000 | -31.4% | 12,584 | -14.3% | 0.00% | -33.3% |
| Q2 2020 | $867,000 | +34.8% | 14,681 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $643,000 | – | 13,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |